Searched for
SENSODYNE MAKER
Haleon to invest Rs 2,000 crore to set up first India plantHaleon is investing Rs 2,000 crore to build its first manufacturing plant in Pithampur, India. This move sharpens its focus on India, a fas...- On their toes: Brands step up anti-counterfeit drive as fake products flood marketsCompanies are fighting a rising tide of fake goods. Brands from toothpaste to cigarettes are changing packaging and tightening checks. Coun...
- Haleon Appoints Former Castrol MD Kedar Lele as India Subcontinent PresidentHaleon has appointed Kedar Lele as president, India subcontinent, succeeding Navneet Saluja. Lele, formerly managing director of Castrol In...
- Haleon may rope in ex-MD of Castrol India to head local bizHaleon India is reportedly set to appoint Kedar Lele, the outgoing MD of Castrol India, as its new chief early next year. Lele will succeed...
- Pfizer to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunnerPfizer is selling around 700 million ordinary shares in Haleon, reducing its stake from 15% to about 7.3%. This sale follows its earlier re...
- GSK intends to sell its remaining stake in HaleonGSK, which initially retained a near 13% stake in Haleon, had over the course of a year lowered its stake to 4.2%. Last year, GSK had said ...
- Self-care products set to grow big; no downtrading in healthcare, says Haleon CEOAccording to Brian McNamara, the global CEO of consumer healthcare company Haleon, the focus on preventive healthcare post-pandemic is crea...
- Sensodyne toothpaste-maker Haleon planning job cutsThe company behind the Sensodyne toothpaste and Advil painkillers was spun off from GSK last year and has more than 24,000 staff globally. ...
- Unilever will not raise rejected 50 bn pound bid for GSK consumer armGSK has rejected three bids from Unilever for its consumer arm, which is home to brands such as Sensodyne toothpaste, Emergen-C vitamin sup...
- GSK sees lower profit this year, split plans on trackThe world's biggest vaccine maker by sales said on Wednesday it expected adjusted earnings to fall by a mid- to high-single digit percentag...
- GSK launches global oral care brand Polident in IndiaDental experts and chemists will play a critical role in establishing the category in India, GSK said in the statement. “The company will w...
- Continued pressure on Horlicks, destocking negatively impacted nutrition business: GSK
- GSK Healthcare banks on Sensodyne, Crocin to drive growth in IndiaIn India, the power brands will be Sensodyne, Panadol (called Crocin in India), nasal decongestant Otrivin and Voltaren pain relieving gels...
- GSK rolls out extensive tooth sensitivity campaign for SensodyneThe campaign – ‘Wake up to tooth sensitivity’ – will involve engagement with consumers, retail initiatives and efforts to increase digital ...
- GSK Consumer Healthcare’s G Venkatramani & Rahul Bibhuti made Sensodyne a successful brandWhile Venkatramani spearheaded Sensodyne’s sales, Bibhuti was responsible for bringing it closer to Indian consumers.
- GlaxoSmithKline Consumer Healthcare signs a brandsswap deal with GSK PharmaceuticalsThe cross-functional collaboration deal, to swap select brands and independently market, sell and distribute them, is one of the four lever...
- GSK's Sensodyne overtakes Colgate in sensitive category within two years of its launchJust two years after its launch in the country, Sensodyne has overtaken Colgate Sensitive to become the top-selling sensitive toothpaste br...
- Challenger brands upset global stars' launch plansA clutch of brands across categories like biscuits, noodles, toothpaste and soaps is upsetting the applecart of established ones by getting...
- India, China new profit centres for GSK ConsumerGlaxosmithkline Consumer Healthcare has elevated India and China into separate profit centres that will report directly to its headquarters...
- GSK re-enters oral care market with SensodyneSensodyne, GSK's biggest global brand with an annual sales of $750 million, has close to a 10% share of the US toothpaste market.
Load More
